Drug study for improving recovery after acute spinal cord injury
Part of Brain & nervous system, Injuries & trauma clinical trials.
This Phase 2 trial tests sotateltide (PMZ-1620) in people with a recent spinal cord injury. It aims to see whether the drug can improve neurological recovery after injury, especially in certain levels and types of incomplete injuries.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 to 75 years old
- Have a recent spinal cord injury and be able to start the study drug within 48 hours
- Have an “incomplete” spinal cord injury on the first exam (not fully complete)
- Not be on a ventilator (breathing support by ventilator disqualifies you)
- Have the injury level in specific spine areas (from C5 to C8, T1 to T12, L1 to L5, or S1 to S5)
- Be medically able to do the study tests and follow the protocol, including pregnancy/birth control rules
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a combination of treatments to help people with certain types of spinal cord injury regain some movement and feeling over time. If you meet the specific injury and health criteria, you may be asked to do simple walking and assessment tests during treatment.
This study tests whether a spinal cord stimulator (a device that sends mild electrical pulses to the spine) can help improve bladder, bowel, and other automatic body functions during inpatient rehab after a recent spinal cord injury. It's for people who have a non-worsening injury at or above the T6 level and are within 4 months of their injury.
This trial studies whether a spinal cord stimulation approach plus rehab can improve function and safety in people with an incomplete spinal cord injury who cannot walk. It may help people by supporting rehabilitation over time, but it requires surgery and specific health and imaging conditions.
This trial tests whether a mild electrical stimulation (called TENS) can help recovery after a recent spinal cord injury. It is for people who are already in the ICU with a drain in their lower back and had a blunt injury within the past 12 hours.
This trial tests a new medicine called TZ-161 in people who have recently had a spinal cord injury in the chest area. The goal is to see if it is safe and can help improve movement.
This trial tests a spinal cord stimulation device to help people with chronic spinal cord injury regain leg movement. It aims to improve muscle control and function.
Hear when a new Acute Spinal Cord Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.